Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy

Infantile spasms syndrome (IS) is a type of epilepsy affecting 1.6 to 4.5 per 10,000 children in the first year of life, often with severe lifelong neurodevelopmental consequences. Only two first-line pharmacological treatments currently exist for IS and many children are refractory to these therapi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EBioMedicine 2022-02, Vol.76, p.103838-103838, Article 103838
Hauptverfasser: Mu, Chunlong, Nikpoor, Naghmeh, Tompkins, Thomas A., Rho, Jong M., Scantlebury, Morris H., Shearer, Jane
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 103838
container_issue
container_start_page 103838
container_title EBioMedicine
container_volume 76
creator Mu, Chunlong
Nikpoor, Naghmeh
Tompkins, Thomas A.
Rho, Jong M.
Scantlebury, Morris H.
Shearer, Jane
description Infantile spasms syndrome (IS) is a type of epilepsy affecting 1.6 to 4.5 per 10,000 children in the first year of life, often with severe lifelong neurodevelopmental consequences. Only two first-line pharmacological treatments currently exist for IS and many children are refractory to these therapies. In such cases, children are treated with the ketogenic diet (KD). While effective in reducing seizures, the diet can result in dyslipidemia over time. Employing a neonatal Sprague-Dawley rat model of IS, we investigated how the KD affects hepatic steatosis and its modulation by a defined probiotic blend. A combination of multiple readouts, including malondialdehyde, fatty acid profiles, lipid metabolism-related enzyme mRNA expression, mitochondrial function, histone deacetylase activity, cytokines and chemokines were evaluated using liver homogenates. The KD reduced seizures, but resulted in severe hepatic steatosis, characterized by a white liver, triglyceride accumulation, elevated malondialdehyde, polyunsaturated fatty acids and lower acyl-carnitines compared to animals fed a control diet. The KD-induced metabolic phenotype was prevented by the co-administration of a blend of Streptococcus thermophilus HA-110 and Lactococcus lactis subsp. lactis HA-136. This probiotic blend protected the liver by elevating pAMPK-mediated signaling and promoting lipid oxidation. The strains further upregulated the expression of caspase 1 and interleukin 18, which may contribute to their hepatoprotective effect in this model. Our results suggest that early intervention with probiotics could be considered as an approach to reduce the risk of hepatic side effects of the KD in children who are on the diet for medically indicated reasons. This study was funded by the Alberta Children's Hospital Research Institute and Mitacs Accelerate Program (IT16942).
doi_str_mv 10.1016/j.ebiom.2022.103838
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8882998</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352396422000226</els_id><sourcerecordid>2628298603</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-5116b960d43afcd0b383f589a5641d61487648a038bb3d6a13e668a724934a193</originalsourceid><addsrcrecordid>eNp9UcFu1DAQtRAVrZZ-ARLykctu7ThxnQNIVVVaRBE9wNma2JPUS2IH26m0J369brdU5cLF9sx7M-N5j5B3nG044_Jku8HOhWlTsaoqGaGEekWOKtFUa9HK-vWL9yE5TmnLGONNXZLqDTkUDa9Vq8QR-XMTQ2mUnUnUhMVnjGAyvcUZSo6mjJBDcgWEJaGl3Y7-whwG9AW1DjMFb-kyRxyWETLSs283X2lyg4fR-YE6T4FOweJIQ1-iHnx2I1Kcyzmn3Vty0MOY8PjpXpGfny9-nF-tr79ffjk_u16bumnzuuFcdq1kthbQG8u6snDfqBYaWXMryzanslZQdOg6YSVwgVIqOK3qVtTAW7Ein_Z956Wb0Br0OcKo5-gmiDsdwOl_Ee9u9RDutFKqaotUK_LhqUEMvxdMWU8uGRxH8BiWpCtZFaKSTBSq2FNNDClF7J_HcKYf3NNb_eiefnBP790rVe9f_vC55q9XhfBxT8Ci053DqJNx6A1aF9FkbYP774B7_tKuSA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628298603</pqid></control><display><type>article</type><title>Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Mu, Chunlong ; Nikpoor, Naghmeh ; Tompkins, Thomas A. ; Rho, Jong M. ; Scantlebury, Morris H. ; Shearer, Jane</creator><creatorcontrib>Mu, Chunlong ; Nikpoor, Naghmeh ; Tompkins, Thomas A. ; Rho, Jong M. ; Scantlebury, Morris H. ; Shearer, Jane</creatorcontrib><description>Infantile spasms syndrome (IS) is a type of epilepsy affecting 1.6 to 4.5 per 10,000 children in the first year of life, often with severe lifelong neurodevelopmental consequences. Only two first-line pharmacological treatments currently exist for IS and many children are refractory to these therapies. In such cases, children are treated with the ketogenic diet (KD). While effective in reducing seizures, the diet can result in dyslipidemia over time. Employing a neonatal Sprague-Dawley rat model of IS, we investigated how the KD affects hepatic steatosis and its modulation by a defined probiotic blend. A combination of multiple readouts, including malondialdehyde, fatty acid profiles, lipid metabolism-related enzyme mRNA expression, mitochondrial function, histone deacetylase activity, cytokines and chemokines were evaluated using liver homogenates. The KD reduced seizures, but resulted in severe hepatic steatosis, characterized by a white liver, triglyceride accumulation, elevated malondialdehyde, polyunsaturated fatty acids and lower acyl-carnitines compared to animals fed a control diet. The KD-induced metabolic phenotype was prevented by the co-administration of a blend of Streptococcus thermophilus HA-110 and Lactococcus lactis subsp. lactis HA-136. This probiotic blend protected the liver by elevating pAMPK-mediated signaling and promoting lipid oxidation. The strains further upregulated the expression of caspase 1 and interleukin 18, which may contribute to their hepatoprotective effect in this model. Our results suggest that early intervention with probiotics could be considered as an approach to reduce the risk of hepatic side effects of the KD in children who are on the diet for medically indicated reasons. This study was funded by the Alberta Children's Hospital Research Institute and Mitacs Accelerate Program (IT16942).</description><identifier>ISSN: 2352-3964</identifier><identifier>EISSN: 2352-3964</identifier><identifier>DOI: 10.1016/j.ebiom.2022.103838</identifier><identifier>PMID: 35148983</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>AMP-Activated Protein Kinases - metabolism ; Animals ; Diet, Ketogenic - adverse effects ; Epilepsy ; Epilepsy - metabolism ; Humans ; Ketogenic diet ; Liver - metabolism ; Nutrition ; Pediatric ; Probiotic ; Probiotics ; Rats ; Rats, Sprague-Dawley ; Steatosis</subject><ispartof>EBioMedicine, 2022-02, Vol.76, p.103838-103838, Article 103838</ispartof><rights>2022 The Authors</rights><rights>Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>2022 The Authors 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-5116b960d43afcd0b383f589a5641d61487648a038bb3d6a13e668a724934a193</citedby><cites>FETCH-LOGICAL-c459t-5116b960d43afcd0b383f589a5641d61487648a038bb3d6a13e668a724934a193</cites><orcidid>0000-0001-9405-5907 ; 0000-0002-2990-2265</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882998/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882998/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35148983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mu, Chunlong</creatorcontrib><creatorcontrib>Nikpoor, Naghmeh</creatorcontrib><creatorcontrib>Tompkins, Thomas A.</creatorcontrib><creatorcontrib>Rho, Jong M.</creatorcontrib><creatorcontrib>Scantlebury, Morris H.</creatorcontrib><creatorcontrib>Shearer, Jane</creatorcontrib><title>Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy</title><title>EBioMedicine</title><addtitle>EBioMedicine</addtitle><description>Infantile spasms syndrome (IS) is a type of epilepsy affecting 1.6 to 4.5 per 10,000 children in the first year of life, often with severe lifelong neurodevelopmental consequences. Only two first-line pharmacological treatments currently exist for IS and many children are refractory to these therapies. In such cases, children are treated with the ketogenic diet (KD). While effective in reducing seizures, the diet can result in dyslipidemia over time. Employing a neonatal Sprague-Dawley rat model of IS, we investigated how the KD affects hepatic steatosis and its modulation by a defined probiotic blend. A combination of multiple readouts, including malondialdehyde, fatty acid profiles, lipid metabolism-related enzyme mRNA expression, mitochondrial function, histone deacetylase activity, cytokines and chemokines were evaluated using liver homogenates. The KD reduced seizures, but resulted in severe hepatic steatosis, characterized by a white liver, triglyceride accumulation, elevated malondialdehyde, polyunsaturated fatty acids and lower acyl-carnitines compared to animals fed a control diet. The KD-induced metabolic phenotype was prevented by the co-administration of a blend of Streptococcus thermophilus HA-110 and Lactococcus lactis subsp. lactis HA-136. This probiotic blend protected the liver by elevating pAMPK-mediated signaling and promoting lipid oxidation. The strains further upregulated the expression of caspase 1 and interleukin 18, which may contribute to their hepatoprotective effect in this model. Our results suggest that early intervention with probiotics could be considered as an approach to reduce the risk of hepatic side effects of the KD in children who are on the diet for medically indicated reasons. This study was funded by the Alberta Children's Hospital Research Institute and Mitacs Accelerate Program (IT16942).</description><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Animals</subject><subject>Diet, Ketogenic - adverse effects</subject><subject>Epilepsy</subject><subject>Epilepsy - metabolism</subject><subject>Humans</subject><subject>Ketogenic diet</subject><subject>Liver - metabolism</subject><subject>Nutrition</subject><subject>Pediatric</subject><subject>Probiotic</subject><subject>Probiotics</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Steatosis</subject><issn>2352-3964</issn><issn>2352-3964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFu1DAQtRAVrZZ-ARLykctu7ThxnQNIVVVaRBE9wNma2JPUS2IH26m0J369brdU5cLF9sx7M-N5j5B3nG044_Jku8HOhWlTsaoqGaGEekWOKtFUa9HK-vWL9yE5TmnLGONNXZLqDTkUDa9Vq8QR-XMTQ2mUnUnUhMVnjGAyvcUZSo6mjJBDcgWEJaGl3Y7-whwG9AW1DjMFb-kyRxyWETLSs283X2lyg4fR-YE6T4FOweJIQ1-iHnx2I1Kcyzmn3Vty0MOY8PjpXpGfny9-nF-tr79ffjk_u16bumnzuuFcdq1kthbQG8u6snDfqBYaWXMryzanslZQdOg6YSVwgVIqOK3qVtTAW7Ein_Z956Wb0Br0OcKo5-gmiDsdwOl_Ee9u9RDutFKqaotUK_LhqUEMvxdMWU8uGRxH8BiWpCtZFaKSTBSq2FNNDClF7J_HcKYf3NNb_eiefnBP790rVe9f_vC55q9XhfBxT8Ci053DqJNx6A1aF9FkbYP774B7_tKuSA</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Mu, Chunlong</creator><creator>Nikpoor, Naghmeh</creator><creator>Tompkins, Thomas A.</creator><creator>Rho, Jong M.</creator><creator>Scantlebury, Morris H.</creator><creator>Shearer, Jane</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9405-5907</orcidid><orcidid>https://orcid.org/0000-0002-2990-2265</orcidid></search><sort><creationdate>20220201</creationdate><title>Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy</title><author>Mu, Chunlong ; Nikpoor, Naghmeh ; Tompkins, Thomas A. ; Rho, Jong M. ; Scantlebury, Morris H. ; Shearer, Jane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-5116b960d43afcd0b383f589a5641d61487648a038bb3d6a13e668a724934a193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Animals</topic><topic>Diet, Ketogenic - adverse effects</topic><topic>Epilepsy</topic><topic>Epilepsy - metabolism</topic><topic>Humans</topic><topic>Ketogenic diet</topic><topic>Liver - metabolism</topic><topic>Nutrition</topic><topic>Pediatric</topic><topic>Probiotic</topic><topic>Probiotics</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Steatosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mu, Chunlong</creatorcontrib><creatorcontrib>Nikpoor, Naghmeh</creatorcontrib><creatorcontrib>Tompkins, Thomas A.</creatorcontrib><creatorcontrib>Rho, Jong M.</creatorcontrib><creatorcontrib>Scantlebury, Morris H.</creatorcontrib><creatorcontrib>Shearer, Jane</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EBioMedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mu, Chunlong</au><au>Nikpoor, Naghmeh</au><au>Tompkins, Thomas A.</au><au>Rho, Jong M.</au><au>Scantlebury, Morris H.</au><au>Shearer, Jane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy</atitle><jtitle>EBioMedicine</jtitle><addtitle>EBioMedicine</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>76</volume><spage>103838</spage><epage>103838</epage><pages>103838-103838</pages><artnum>103838</artnum><issn>2352-3964</issn><eissn>2352-3964</eissn><abstract>Infantile spasms syndrome (IS) is a type of epilepsy affecting 1.6 to 4.5 per 10,000 children in the first year of life, often with severe lifelong neurodevelopmental consequences. Only two first-line pharmacological treatments currently exist for IS and many children are refractory to these therapies. In such cases, children are treated with the ketogenic diet (KD). While effective in reducing seizures, the diet can result in dyslipidemia over time. Employing a neonatal Sprague-Dawley rat model of IS, we investigated how the KD affects hepatic steatosis and its modulation by a defined probiotic blend. A combination of multiple readouts, including malondialdehyde, fatty acid profiles, lipid metabolism-related enzyme mRNA expression, mitochondrial function, histone deacetylase activity, cytokines and chemokines were evaluated using liver homogenates. The KD reduced seizures, but resulted in severe hepatic steatosis, characterized by a white liver, triglyceride accumulation, elevated malondialdehyde, polyunsaturated fatty acids and lower acyl-carnitines compared to animals fed a control diet. The KD-induced metabolic phenotype was prevented by the co-administration of a blend of Streptococcus thermophilus HA-110 and Lactococcus lactis subsp. lactis HA-136. This probiotic blend protected the liver by elevating pAMPK-mediated signaling and promoting lipid oxidation. The strains further upregulated the expression of caspase 1 and interleukin 18, which may contribute to their hepatoprotective effect in this model. Our results suggest that early intervention with probiotics could be considered as an approach to reduce the risk of hepatic side effects of the KD in children who are on the diet for medically indicated reasons. This study was funded by the Alberta Children's Hospital Research Institute and Mitacs Accelerate Program (IT16942).</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35148983</pmid><doi>10.1016/j.ebiom.2022.103838</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-9405-5907</orcidid><orcidid>https://orcid.org/0000-0002-2990-2265</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2352-3964
ispartof EBioMedicine, 2022-02, Vol.76, p.103838-103838, Article 103838
issn 2352-3964
2352-3964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8882998
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects AMP-Activated Protein Kinases - metabolism
Animals
Diet, Ketogenic - adverse effects
Epilepsy
Epilepsy - metabolism
Humans
Ketogenic diet
Liver - metabolism
Nutrition
Pediatric
Probiotic
Probiotics
Rats
Rats, Sprague-Dawley
Steatosis
title Probiotics counteract hepatic steatosis caused by ketogenic diet and upregulate AMPK signaling in a model of infantile epilepsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A01%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Probiotics%20counteract%20hepatic%20steatosis%20caused%20by%20ketogenic%20diet%20and%20upregulate%20AMPK%20signaling%20in%20a%20model%20of%20infantile%20epilepsy&rft.jtitle=EBioMedicine&rft.au=Mu,%20Chunlong&rft.date=2022-02-01&rft.volume=76&rft.spage=103838&rft.epage=103838&rft.pages=103838-103838&rft.artnum=103838&rft.issn=2352-3964&rft.eissn=2352-3964&rft_id=info:doi/10.1016/j.ebiom.2022.103838&rft_dat=%3Cproquest_pubme%3E2628298603%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2628298603&rft_id=info:pmid/35148983&rft_els_id=S2352396422000226&rfr_iscdi=true